AlphaMadera's AlphaVal page computes H&R Block, Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag HRB as undervalued, fairly valued, or overvalued.

What is H&R Block, Inc.'s fair value?

Fair value for HRB is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value HRB?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from HRB's most recent reported fundamentals.

HRB - H&R Block, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $41.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Moderate

Trading 31.9% below fair value

Current Price $41.85

Bear Case $49.15 17.4% upside ($49.15 - $41.85) / $41.85 = 17.4% $4.55 × 12x P/E

Fair Value $61.43 46.8% upside ($61.43 - $41.85) / $41.85 = 46.8% $4.55 × 15x P/E

Bull Case $73.72 76.1% upside ($73.72 - $41.85) / $41.85 = 76.1% $4.55 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

4.55$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 9.2x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $41.00 from 16 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $61.43 per share.

Warnings

ℹ Wall Street's average price target is $41.00 (from 16 analysts). Our estimate is 66% above the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples